Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells.
about
Prostate cancer invasion and metastasis: insights from mining genomic data.Changes in the transcriptional profile in response to overexpression of the osteopontin-c splice isoform in ovarian (OvCar-3) and prostate (PC-3) cancer cell lines.Osteopontin knockdown suppresses the growth and angiogenesis of colon cancer cells.Runx2-Smad signaling impacts the progression of tumor-induced bone diseaseOsteopontin-c mediates the upregulation of androgen responsive genes in LNCaP cells through PI3K/Akt and androgen receptor signaling.Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis.Osteopontin-a splice variant is overexpressed in papillary thyroid carcinoma and modulates invasive behavior.Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancersIntegrin β3 and CD44 levels determine the effects of the OPN-a splicing variant on lung cancer cell growth.Suppression of osteopontin inhibits chemically induced hepatic carcinogenesis by induction of apoptosis in miceRole of osteopontin in the pathophysiology of cancer.Osteopontin as a therapeutic target for cancer.Osteopontin splice variants expression is involved on docetaxel resistance in PC3 prostate cancer cells.Evaluation of copy number variation and gene expression in neurofibromatosis type-1-associated malignant peripheral nerve sheath tumours.The osteopontin-c splice junction is important for anchorage-independent growth.Human osteopontin: Potential clinical applications in cancer (Review)Osteopontin (OPN) isoforms, diabetes, obesity, and cancer; what is one got to do with the other? A new role for OPN.Increased osteopontin expression is associated with progression from vulvar precancerous lesions to vulvar squamous cell carcinoma.OPN b and c Isoforms Doubtless Veto Anti-angiogenesis Effects of Curcumin in Combination with Conventional AML Regiment
P2860
Q30656758-7F434737-004C-4842-9D78-724FBF9AB073Q33823827-46A3C707-789C-4AFF-A5D3-35A499EFF3CBQ34036685-B20F57FC-69E5-4260-925D-CB1CC911798CQ34898865-C5D8E3D5-41AB-46BD-BD88-54254D5059D9Q35167752-B4EFF287-D91C-4AB7-B98D-D6BC9ACA0BBBQ36663581-97C6191B-5998-4525-9179-F2F1E78E7092Q37588399-1E7C423B-B05A-4C8F-BFFC-33A24819EDAFQ37625382-562FAFD4-EF8C-4AD5-A517-80439E7A099DQ37688275-2544DAF1-D697-43D7-853D-8F969327BC3FQ37699402-3C95FC1A-2B73-4D66-BD6B-3A78BD0E95C0Q38198463-CFE23058-C735-417C-8E2E-A30613A8796EQ38217758-8808B300-BB2A-492F-AFF3-F52F7869CCEAQ38832738-9A23CF80-BBAF-4769-A339-D6D7B4914F12Q38885862-CE94C583-5E90-44E8-9DFE-441E6D462C55Q39202707-39C5987C-C600-4480-BD25-B67641507DD0Q39261041-B674931E-2341-489B-A69F-D84901441199Q41590198-E2BADA9D-1CEF-47E1-BEF2-9056CADCAC26Q46198382-A0E20727-88EE-48F5-B5AF-1C0A71BD803EQ47149829-BEF5CF24-AB84-413C-883F-B37E8A874A37
P2860
Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Both osteopontin-c and osteopo ...... oles in prostate cancer cells.
@en
Both osteopontin-c and osteopo ...... oles in prostate cancer cells.
@nl
type
label
Both osteopontin-c and osteopo ...... oles in prostate cancer cells.
@en
Both osteopontin-c and osteopo ...... oles in prostate cancer cells.
@nl
prefLabel
Both osteopontin-c and osteopo ...... oles in prostate cancer cells.
@en
Both osteopontin-c and osteopo ...... oles in prostate cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
Both osteopontin-c and osteopo ...... oles in prostate cancer cells.
@en
P2093
Akeila Bellahcène
Aline R Matos
Etel R Gimba
Kivvi D Mello
Luciana B Ferreira
Maria Thereza S Accioly
Paulo A S Faria
Tatiana M Tilli
Vincent Castronovo
P2860
P304
P356
10.1002/PROS.22523
P577
2012-04-11T00:00:00Z